Group like-for-like (LFL) net revenue growth of +6.0%.
Growth was broad-based across our Global Business Units (GBUs), with a strong innovation programme. On an IFRS basis net revenue grew by +8.1%.
Hygiene LFL net revenue growth of +3.6%
Growth was driven by Finish, Harpic, Vanish and Air Wick, and underpinned by early success of innovation launches.
Health LFL net revenue growth of +8.8%.
Growth was led by our OTC portfolio and Intimate Wellness brands with an improving performance in China. Dettol declined by mid-single digits with category decline and in-market challenges across certain Asian markets – we expect an improvement in H2.
Nutrition LFL net revenue growth of +5.3%
Continued strong market share in North America and mid-single digit growth in LATAM, against the lapping of tough prior year comparatives due to the US competitor supply issue.
Adjusted operating margin of 23.8% (-180bps)
Productivity efficiencies and carry-over pricing drove gross margin expansion, and funded increased investment behind innovation launches.
Adjusted diluted EPS of 173.0p (-3.1%)
Net revenue growth and positive impact from foreign exchange is offset by lower operating margins and a higher effective tax rate.
H1 2023 dividend recommended to be 76.6p
The increase of 5% is consistent with our aim to deliver sustainable dividend growth.